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Abstract Furostanol glycoside 26-O-~-glucosidase (F26G) pur- 
ified from Costus speciosus rhizomes was digested with 
endoproteinase, and several internal peptide fragments were 
obtained. Degenerate oligonucleotide primers based on amino 
acid sequences of the peptides were used for amplification of 
F26G cDNA fragments by applying nested polymerase chain 
reactions to cDNAs from in vitro cultured plantlets of C. 
speciosus. Using primers based on sequences of the cDNA 
fragments, the 5'- and 3'-end clones were isolated by rapid 
amplification of cDNA ends (RACE) methods. Finally, the entire 
coding portion of F26G cDNA was cloned by using primers 
designed from sequences of the RACE products. The deduced 
amino acid sequence of CSF26G1, the protein encoded by the 
cloned cDNA, consists of 562 amino acids and shows high 
homology to a widely distributed family of ~-glucosidases (BGA 
family). Cell-free homogenate of Escherichia coli expressing 
CSF26G1 cDNA showed [~-glucosidase activity specific for 
cleavage of the C-26 glucosidic bond of furostanol glycosides. 
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1. Introduction 
Steroid saponins are glycosides found in a wide range of 
plant species, which show characteristics such as forming a 
soapy lather when shaken with water, antifungal and hemo- 
lytic activities. Most of them are spirostane derivatives con- 
taining one oligosaccharide moiety attached at C-3 [1]. They 
are formed from furostanol glycosides, whose F-ring is held 
open by an additional glucose moiety attached at C-26, during 
postharvest treatment and storage of the plants [2,3]. The 
enzyme responsible for this conversion is called furostanol 
glycoside 26-O-13-glucosidase (F26G) [4]. In contrast o spiro- 
stanol glycosides, furostanol glycosides do not show typical 
saponin characteristics [5]. 
Oat (Arena sativa) leaves accumulate another type of ster- 
oid saponins, the aglycone of which is a furospirostane deriv- 
*Corresponding author. Fax: (81) (3) 5689 2962. 
Abbreviations: F26G, furostanol glycoside 26-O-I]-glucosidase; IPTG, 
isopropyl 13-D-thio-galactopyranoside; PCR, polymerase chain reac- 
tion; pNPG, p-nitrophenyl ~-D-glucopyranoside; RACE, rapid ampli- 
fication of cDNA ends; SDS-PAGE, sodium dodecyl sulfate 
polyacrylamide g l electrophoresis 
The nucleotide sequence data reported in this paper will appear in the 
DDBJ, EMBL, and GenBank nucleotide sequence databases with 
accession umber D83177. 
ative nuatigenin, whose F-ring is a five-membered furan ring 
instead of a six-membered pyran ring as in spirostane. Ave- 
nacosides are nuatigenin glycosides, which are similar to furo- 
stanol glycosides in containing two sugar moieties attached at 
C-3 and C-26, and in not showing typical saponin activities. 
Antifungal 26-desglucoavenacosides ar  formed from avena- 
cosides by avenacosidase in oat leaves [6]. This conversion has 
been presumed to be a plant defense against fungal attack 
[6,7]. Two groups independently reported purification and 
characterization f avenacosidase from oat leaves [6,7]. 
Gurielidze t al. reported the partial purification of F26G, 
which they called 'oligofurostanoside-specific I]-glucosidase', 
from Dioscorea deltoidea [8]. Their preparations showed a 
Km of 0.83-0.90 mM for a native furostanol glycoside delto- 
side [8]. However, in contrast to avenacosidase, F26G has not 
been purified or characterized yet. 
Costus speciosus (Koenig) Smith (Zingiberaceae) contains a 
large amount of spirostanol glycosides, all of which yield 
diosgenin as the sole sapogenin [9], whereas the sapogenins 
obtained from most other saponin-producing plants show 
structural heterogeneity [2]. We have recently detected F26G 
activity in C. speciosus by using the highly sensitive assay 
method [10], and then purified F26G from rhizomes [4] and 
from whole parts of in vitro cultured plantlets [11]. The pur- 
ified F26Gs specifically cleaved the C-26 glucosidic bond of 
furostanol glycosides and showed a Km for protogracillin, a 
major furostanol glycoside of C. speciosus [9], of 50 ~tM (from 
rhizomes) [4] or 82 ~tM (from in vitro cultured plantlets) [11]. 
The F26Gs from the two materials were identical in Mr de- 
termined by both gel filtration HPLC (110000) and SDS- 
PAGE (54000 and 58 000), and in the N-terminal sequence 
of the 54 000 protein [4,11]. 
This publication describes the cloning, sequencing, and bac- 
terial expression of a cDNA encoding C. speciosus F26G. This 
is the first report on the cDNA for a plant 13-glucosidase 
responsible for the saponin metabolism. 
2. Materials and methods 
2.1. Sequence analysis of peptides from proteolysed F26G 
The F26G purified from C speciosus rhizomes as previously de- 
scribed [4] was subjected to a reverse phase HPLC column of phen- 
yl-5PW RP. The protein eluted as a single peak was collected and then 
digested with endoproteinase Lys-C (Boehringer Mannheim, Ger- 
many) in 50 mM Tris-HC1, pH 8.5. The digested fragments were 
separated on a column of C-18, and each collected peptide was sub- 
jected to amino acid sequence analysis using a Shimadzu protein 
sequencer PSQ-1. 
2.2. RNA isolation and reverse transcription 
RNA was extracted from plantlets of C. speciosus cultured in vitro 
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as previously described [10]. Whole parts of the 2-3-month-old plant- 
lets were frozen in liquid nitrogen, homogenized with a mortar and 
pestle in a mixture of 1 M Tris-HC1, pH 9, phenol saturated with TE 
(10 mM Tris and 1 mM EDTA-HC1, pH 8), and 10% SDS, in 10:10:1 
by volume. After the centrifugation for 5 rain at 18 500×g, the aque- 
ous phase was extracted again with equal volume of phenol-chloro- 
form-isoamylalcohol (25:24:1), and 70% ethanol was added to pre- 
cipitate the nucleic acids. The pellet was dissolved in TE, and RNA 
was isolated by LiC1 precipitation [12]. Two cDNA pools (1 and 2) 
were prepared by reverse transcription of the RNA using SUPER- 
SCRIPq~II (Gibco-BRL, Gaithersburg, MD) according to the man- 
ufacturer's protocol with oligo dT nucleotide primer T1 (for cDNA 
pool-1 ; Table 1) or with F26G cDNA-specific primer RT (for cDNA 
pool-2; Table 1). Poly(A) tail was added to cDNA pool-2 using term- 
inal deoxynucleotidyl transferase (Toyobo, Osaka, Japan) according 
to Frohman et al. [13]. 
2.3. Amplification of F26G cDNA fragments by PCR and sequencing 
All oligonucleotides u ed for the F26G cDNA cloning are listed in 
Table 1. A schematic representation f the cloning strategy is shown 
in Fig. 1. A nested PCR method, where each cDNA fragment is 
cloned by two-step amplification [14], was employed. In the first 
step, 'primary fragment' was generated with a first set of primers 
(P1 and P2 for A and B; P1 and P7 for C; Tx and P9 for 5'-RACE 
[13] product D; P10 and T1 for 3'-RACE [13] product E; Pa and Pb 
for F). The template used for reactions other than 5'-RACE was 
cDNA pool-1, cDNA pool-2 was used as template for 5'-RACE. In 
the second step, each of the objective cDNA fragment was cloned 
with a second set of primers nested within the first (shown in Fig. 
1) using the primary fragment as template. All PCR amplifications 
were performed in 100-~1 reaction volumes containing template DNA, 
primers (1 p.g each), dNTPs (0.2 mM each), and 2.5 units of Taq 
DNA polymerase (Promega, Madison, WI) for fragments A, B, C, 
D, and E amplifications, or Ex Taq (TaKaRa Biochemicals, Osaka, 
Japan) for fragment F amplification, in the buffer supplied with the 
each enzyme. The conditions were 30 cycles of 1 min at 94°C, 1 min at 
42°C (for amplifications of A and B) or 52°C (for amplifications of C, 
D, E, and F), and 1.5 min at 72°C, followed by a 10-min final exten- 
sion at 72°C. Each amplified PCR fragment was directly ligated with 
pT7Blue(R) T-vector and transformed into NovaBlue competent cells 
according to the supplier's protocol (Novagen, Madison, WI). Plas- 
mid DNA was purified using the Wizard Midipreps DNA Purification 
System (Promega, Madison, WI). Nucleotide sequences of the sub- 
cloned cDNA fragments were determined by the dideoxy chain termi- 
nation method [15] using a Hitachi DNA sequencer SQ-3000 and the 
sequencing kit for Sequenase Version 2.0 (Toyobo). 
2.4. Expression of F26G cDNA in E. coli 
E. coli NovaBlue transformed with pT7Blue(R) or pT7-CSF26G1 
(the ligation product of pT7Blue(R) T-vector and the cDNA fragment 
F) was grown at 37°C in LB medium with 50 ~tg/ml ampicillin and 0.1 
mM IPTG until the culture was saturated (about 14 h). The cells were 
harvested by centrifugation (15 min at 5000×g), resuspended in 0.1 M 
potassium phosphate buffer, pH 7, lysed by sonication, and insoluble 
materials were removed by centrifugation for 15 min at 8000×g. A 
clear supernatant was used for further analysis. Protein concentration 
was determined by the Bradford assay [16] using reagents purchased 
from Bio-Rad (Hercules, CA) and bovine serum albumin as standard. 
13-Glucosidase activities were examined as previously described [4]. 
An expression system based on the phage T7 RNA polymerase gene 
[17] was also employed. The recognition motif for the restriction en- 
zymes NcoI and BamHI were designed in PCR primers Pc and pd, 
respectively (Table 1). Using the two restriction enzymes, the coding 
portion of the CSF26G1 cDNA was obtained from plasmid pT7- 
CSF26G1 and then subcloned into the plasmid vector pET3d to gen- 
erate pET-CSF26G1. The proper construction of the resulting plas- 
mid was confirmed by restriction fragment analysis. E. coli 
BL21(DE3) transformed with pET3d or pET-CSF26G1 was grown 
at 37°C in LB medium with 50 ~tg/ml ampicillin until its ODr00 
reached approx. 0.6. The recombinant protein expression was induced 
by adding IPTG to 0.1 mM and continued for 5 h. Cell lysate was 
prepared and analyzed as described above. 
3. Results and discussion 
The F26G purified from C. speciosus rhizomes [4] was 
eluted as a single symmetrical peak from a column of phen- 
yl-5PW RP, which gave only one band with Mr of 54 000 by 
SDS-PAGE (9.6% gel; data not shown). This protein was 
digested with Lys-C and proteolytic fragments were separated 
by reverse phase HPLC. Eight internal peptides were se- 
quenced. Four  of them (a, b, c, and d) showed high homology 
with black cherry amygdalin hydrolase I (AH I) [18] at resi- 
dues 151-182, 340-361,466-480, and 481~95 (numbering of 
the black cherry protein), respectively, in their amino acid 
Table 1 
Oligonucleotides u ed for the F26G cDNA cloning ~ 
Sequence (5' to 3') b Designed from Strand c 
Pa CCIGCIGARGTIGTIYTIGGIMGIWSIWSITT N-terminal + 
P2 TTRTCRTARTCDATRTGDATIARICC peptide fragment-d - 
P3 GICCIATGGTIACIYTITTYCAYTGG peptide fragment-a + 
P4 GTRAAIGGIGTRTGYTGIGCRTARTT peptide fragment-b - 
P5 TAYGAYTTYATHGGIATHAAYTAYTAYAC peptide fragment-b + 
P6 TGCCAYTCRAARTTRTCIGTIARIGCCCA peptide fragment-c - 
P7 TCTCAGAGCTTCGAAAGCCTTG PCR fragment-A - 
P8 ACGAGTCCTCCAGCGCCTGAGG PCR fragment-A - 
P9 GCGATCCTGTCCGGATGGTCGTGT PCR fragment-C - 
P10 GAATACCTCACCTACCATCTCG PCR fragment-B + 
Pll CAAGTCCTCCAAGCCATTCGGG PCR fragment-B + 
RT TTAACGCCGCCTTGTAATGTGCCC PCR fragment-C - 
P~ GCCAGCGGATAGACATTAG PCR fragment-D + 
Pb TCTGACTTCATCCATAGC PCR fragment-D - 
Pc d TCATAG CCATGGGCCGCTCAGTTAGGGCTT PCR fragment-E + 
NcoI 
TTCATC GGAT CCTCACGTCCTCAGGAACTrG 
BamHI 
GACTCGAGTCGACATCGATTTTTTTTTTTTTT 
CGATTTTTTTTTTTTI'T 
Pd d PCR fragment-E 
T1 
T2 
aRT primer was used as F26G cDNA-specific primer for reverse transcription i  5'-RACE. Other primers were used for the nested PCRs as 
described in Section 2 and Fig. 1. 
bD denotes A or G or T; M, AorC;  R, Aor  G; S, CorG;W,  AorT ;  Y, CorT .  
c+ indicates the coding strand, - the complementary strand. 
dOriginal nucleotides of the PCR product D or E were replaced by italic ones, which introduced the desired restriction sites (underined); ATG 
corresponds to the start codon; TCA corresponds to the inverted sequence for the stop codon TGA. 
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I I 
PaPc PI 
P~ 
D/500 bp/ 
P9 RT P3PsP7 
P~ A(600bp) 
C/400bpI p~ 
P9 
F (1.7 kb) 
[ I AAA 
PsP4 PIOPII PoP2 PdPb 
Pa 
po ~(400bp1 p~ 
P~l E (600b~) T: 
Pa 
Fig. 1. Strategy for F26G cDNA cloning. The topmost diagram 
shows the full length F26G cDNA; the open box represents he 
coding region, and the solid lines represent the 5'- and 3'-untrans- 
lated regions. The arrows below the diagram show the direction and 
location of oligonucleotide primers in relation to the F26G cDNA 
above. Lines A through F represent cDNA fragments amplified by 
nested PCRs as described in Section 2. Nested primers are shown 
beside ach PCR product. 
sequences. Based on these sequence similarities, the relative 
location of the four internal peptides could be predicted. 
A nested PCR method [14] was employed for the F26G 
cDNA cloning. RNA was extracted from in vitro cultured 
plantlets because they are suitable for RNA preparation com- 
pared to the rhizomes. Based on the amino acid sequences of 
the N-terminus of the 54 000 protein [4,11] and the four inter- 
nal peptides a~l, degenerate oligonucleotide primers were de- 
signed and used to amplify internal cDNA fragments A and B 
(Fig. 1, Table 1). Another internal cDNA fragment C was 
obtained using oligonucleotide primers based on the fragment 
A and one degenerate primer (Fig. 1, Table 1). Using primers 
designed from the cDNA fragments B and C, the 5'-end clone 
D and the 3'-end clone E were isolated by RACE methods 
[13] (Fig. 1, Table 1). Finally, a 1.7-kb fragment, which was 
expected to contain the entire coding region of the F26G 
cDNA, was cloned using primers whose sequences were ob- 
tained by analysis of the 5'- and Y-RACE products D and E, 
respectively (Fig. 1, Table 1). This clone was designated 
CSF26G1 cDNA and used for further analysis. 
DNA sequence was determined from both strands to ensure 
its accuracy. The nucleotide sequence of the CSF26G1 cDNA 
and the deduced amino acid sequence are shown in Fig. 2. 
The cloned cDNA consists of a 1686-nucleotide open reading 
frame which encodes a 562 amino acid long protein. The 
deduced primary structure of the CSF26G1 contains se- 
quences imilar to those of 156 amino acid residues which 
were determined for the N-terminus of the 54000 protein 
[4,11] and the eight internal peptides of the purified enzyme. 
However, 18 of the 156 amino acid residues did not match, 
Table 2 
~l-Glucosidase activity in the cell-free homogenate of transformed E.
coli 
Plasmid/host Substrate 
Protogracillin pNPG 
pT7Blue(R)/NovaBlue < 15 < 0.3 
pT7-CSF26G1/NovaBlue 430 3.2 
pET3d/BL21(DE3) < 15 < 0.3 
pET-CSF26G 1/BL21 (DE3) 130 2.1 
I~-Glucosidase activities are expressed aspkat/mg protein. The results 
of the experiments were consistent inseveral trials, and the data for a 
representative experiment are shown. 
indicating the protein encoded by CSF26G1 cDNA is similar 
to but different from the purified enzyme. In addition, the 
sequence of CSF26G1 cDNA was not completely identical 
with those of the five PCR products (identity of CSF26G1 
cDNA with each cDNA fragment A, B, C, D, and E in their 
nucleotide sequences is 74.8%, 96.6%, 88.1%, 91.8%, and 
91.1%, respectively). This multiplicity of PCR products could 
not be explained by artifact formations due to mistakes of the 
polymerase since the high fidelity (> 99%) was addressed un- 
der the optimum condition [19]. These results uggest the pres- 
ence of CSF26G1 homologues. CSF26G1 cDNA should en- 
code one of the C. speciosus F26G isozymes which might exist 
as a minor protein in the rhizomes. 
I~-Glucosidases are known to fall into two distinct families 
(BGA and BGB) based on their structure similarities rather 
than their biological roles and substrate specificities [20,21]. 
The BGA family includes bacterial ~-glucosidases, archaebac- 
terial I~-galactosidase, plant thioglucosidases, and human lac- 
tase-phlorizin hydrolase, while the BGB family includes fun- 
gal and rumen bacterial I~-glucosidases [18,21]. All of the 
seven plant I~-glucosidases ncoded by the cDNAs which 
have been cloned so far were found to belong to the BGA 
family [18,22-26]. The BGA family enzymes are predicted to 
share a common mechanism of enzymatic hydrolysis of 13- 
A~TTA~CACTCGTCTCCTGCCACCGCGGCGCCAGCCAAGCTGCCAGTAGCAGCGCC 72 
M A A Q L G L P L V S C H R G A S Q A A S S S A 24 
CACTTGGTGCC ~ G C G C  CATCA%~-AGGC CGGGAACAGGAGGCAGAAGATGA A 144 
H L V P G A S A I M Q A G N R R Q K M R A P A L 48 
GCC~TGCCTGTGGATC~C-C ~ T ~ ~  C ~ C ~ G  216 
R D R V V F A R V V P V D G S V G F A G S S T E 72 
CAGGAGACCGCGGTCGAGTCGGCCACCCCAACIGCCGT?CCCTCGAASGTCGTCCTC 288 
Q E T A V E S A T P T A V P S K V V L G R S S F 96 
N- terA  V P A E V V L G R S S F 
C ~ ~ TGC~/~C C ~ A C  CAGG~U~AAGGAGCTTGGAATGAAGGAGGGAGA 360~ g ~ ~ ~ v ~ ~  12o 
GG TC CGAC-CATATGGGATAC CI'PTACACACGACCATC GC*AGAAGATCGCAGAC CACAGCAA~T~ 432 
G P S I W D T F T H D H P E K I A D H S N G D K 144 
GCAAOIkV4%%~fCGTACAAGAAATACAAC~ATGTGAAGCTG~=A ACAGA 504 
A T D S Y K K Y K E D V K L L K D L G L D S Y R 168 
TTTTCCATC~ TCAAGGATATTC, CCC~/~GGCACA~ACAAC~T?AATCAGGAAGGGATTCAG 573 
F S I S W S R I L P K G T L Q G G I N Q E G I Q 192 
TAT~ACAATGATCTGATCAACGA q~43TAT?AGGC CTA%~3Gq?ACAq~3~TC CACT~GGAC 648 
G~ CTCAGGCGq~C~fC CTACAAA~ I "r F I L ~ 3 A A C ~ T T ~ ~ C T A C  720 
A D I C F K E F G D R V K H W I T L W S L 264 
AGCAC CATGGGG TATGCGTTTGGCAGGCATGCAC ~=ATGC T 864 
S T M G Y A F G R H A P G R C S T W Y G C P A G 288 
GA~TGAACCCTA~CCACAACCTC~CCATGCAAATGCCGTCAAAATITAC 936 
D S A N E P Y E V T H N L L L A H A N A V K I Y 312 
AGGGATAACTATAAGGCTACTCAAAA~TAGGGATTA~C~q~3GTATGAGCCATAC 1008 
TCAAAGTCTCACGAAGA CTAGAGC TCTGGAC~"F I~TGGTACATGGAC C CC 1080 
T I~G~GAACGGC GACTA~C ATTCATCAqF~%GGGCAC ~ ~ A C  C CACGCG 1152 
L V N G D Y P F I M R A L V R D R L P F F T H A 384 
L V N G D Y P F 
G ~  TGATCAAAGGATCTTATGACTTCATTGGAATCAAq~ATTACA~T~ATGCTCAGCAT 1224 
GCGC ~ G A C  CACACA~CAAT~TA~TI~T~ATGTAAATCAA . 1296 
A P V T E D H T P D N S Y F D S Y V N Q S G E K 432 
T P F T 
AATGGTGTICCAATAGGGCCA TATACTTTTATCCA .CTITn~ 1368 
N G V P I G P L Q G S W I Y F Y P R G L K E L L 456 
~ACGTAAAGAGAAGATACTGCAACCCAAAGAq~TAC~CnCC~-~C~ ~ ~ ~ -(3 1440 
L Y V K R R Y C N P K I Y I I T E N G |T  A E V E K 480 
GAGAAGGGC~ TACCACT~CATGAC ~ G G A A  l~c~" ~ tu%cc" I'A~ ~A'I ~ fCGC C CAAGTC C~C CAA 1512 
E K G V P L H D P E R K E Y L T Y H L A Q V L Q 504 
GCCA CGTGAA~/~GGCACTTTA CTGATAACI~IL~IA~ TGGGAC3bAA 1584 ~ ~ V ~ o ~ ~ ~ g g ~  528 
GGC TACACAGAGCGTTTYGGTCTCATITATATIGATTATGACAA T ITCAATCGTCAAC CAAGGA~TC T 1656 
G Y T E R F G L I Y I D Y D K D F N R Q P K D S 552 
~G Y T E R F G L I H I D Y D K 
AC CAAGTGGTTCAGCAAGTICCTGAGGACGTGA 1689 
T K W F S K F L R T * 562 
W F S K 
Fig. 2. Nucleotide sequence of CSF26G1 cDNA and deduced amino 
acid sequence. The sequenced amino acids are indicated below the 
deduced amino acid sequence underlined. Amino acid with letter X 
denotes a position of an unidentified residue. The sequence followed 
by the letter N-ter represents he N-terminal sequence of the 54 000 
protein determined previously [4,11]. The peptide sequences u ed for 
design of degenerate oligonucleotide primers follow the letter a, b, c, 
and d, respectively (Table 1, Fig. 1). The motif Asn-Glu-Pro, con- 
taining the likely acid-base catalytic residue Glu 26°, and the motif Ile- 
Thr-Glu-Asn-Gly, which includes the predicted active site nucleophile 
Glu 472, are within boxes. 
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glycosidic bonds based on their primary structure similarities 
[27]. Highly conserved Ile/Val/Leu-Thr/Ser-Glu-Asn-Gly and 
Asn-Glu-Pro motifs have been identified to contain an active 
nucleophilic enter [28-30] and an acid-base catalyst [30,31], 
respectively (Fig. 3). The deduced amino acid sequence of 
CSF26G1 was compared with other known protein sequences 
in the data base and revealed to have high homology with the 
BGA family proteins throughout their entire sequences (data 
not shown); it shows 33-53% identity with those of the 10 
BGA family proteins listed in Fig. 3. The highest similarity 
was observed with amygdalin hydrolase 1 (AH I) which is 
involved in cyanogenesis of black cherry [18]. In addition, 
the deduced sequence of CSF26G1 contains the highly con- 
served two putative active site motifs (Fig. 3). Therefore, we 
concluded that CSF26G1 belongs to the BGA family. 
When E. coli NovaBlue bearing pT7-CSF26G1 was grown 
on LB medium supplemented with IPTG, the cell lysate 
showed 13-glucosidase activity specific for removal of the C- 
26 bound glucose of protogracillin to form gracillin (Fig. 4, 
Table 2). The activity was absent in control using the cell 
lysate from E. coli transformed with the vector pT7Blue(R) 
alone. Protodioscin, another major furostanol glycoside of 
C. speciosus [9], was also hydrolyzed by the CSF26G1 
cDNA product at the same level as protogracillin (data not 
shown). Neither the hydrolysis of furostanol glycoside nor the 
production of spirostanol glycoside was detected when boiled 
lysate of each cell was assayed. In preliminary experiments, 
the cell-free homogenate of the bacteria expressing CSF26G1 
cDNA was shown to be almost inactive toward 26-glucosidic 
bond of a nuatigenin glycoside (a generous gift from Dr. Y. 
Mimaki, Tokyo College of Pharmacy) (data not shown). 
These results vigorously proved that the protein encoded by 
the cloned cDNA is a furostanol glycoside 26-O-13-glucosid- 
ase. An attempt to obtain sufficient amount of CSF26G1 
cDNA product was made by using the strong expression sys- 
tem with the pET vector [17]. Although the cell lysate of E. 
Enzyme Acid/base Nucleophile 
+ + 
CSF26GI (260, 472) 
AH I (207, 421) 
As-P60 (238, 454) 
BGQ60 (205, 415) 
CAS5 (198, 413) 
TREI04 (194, 408) 
TRE361 (204, 422) 
Zm-p60.1 (245, 460) 
ABG5 (171, 359) 
BGLA (166, 355) 
LPH3 (182, 390) 
HITLNEI 
HITLNEI 
~T~NEI  
~T~NEI  
~ITLNEI 
T~ilNNI 
{ITENG~k 
fITENGq 
~ ENG~ 
-",ITENG~ 
fITENG i 
gITENG~' 
Fig. 3. Alignment of equivalent regions surrounding the putative 
acid/base and nucleophile of BGA family 13-glucosidases. Numbers 
in parentheses denote the residue numbers of the conserved gluta- 
mate (acid/base) and glutamate (nucleophile), which are indicated 
by '+' in the above line, respectively. Residues identical with those 
of CSF26G1 are shown as white characters on a black background. 
The enzyme abbreviations are as follows: AH I, Prunus serotina 
amygdalin hydrolase I [18]; As-P60, A vena sativa 13-glucosidase [22]; 
BGQ60, Hordeum vulgate I~-glucosidase [23]; CAS5, Manihot escu- 
lenta linamarase [24]; TRE104, Triforium repens cyanogenic 13-gluco- 
sidase [25]; TRE361, T. repens noncyanogenic 13-glucosidase [25]; 
Zm-p60.1, Zea mays [3-glucosidase [26]; ABG5, Agrobacterium ~- 
glucosidase [35]; BGLA, Bacillus circulans ~-glucosidase [36]; LPH3, 
Homo sapiens lactase-pholorizin hydrolase domain 3 [37]. 
G : Gracillin 
D-Glucose GIc-O 
GIc..3 
Rha/~ Ic-O P : Protogracillin 
A-1 
G 
A-2 
P 
M 
P 
B-1 
G 
B-2 
' 1() . . . .  6.0 .0 14.0 6.0 10.0 14.0 
Time (rain) Time (min) 
Fig. 4. HPLC analysis of the F26G activity in cell-free homogenate 
of transformed E. coli. A: Reaction product with the cell lysate 
from E. coli NovaBlue transformed with pT7-CSF26G1 (A-I) or 
pT7Blue(R) (A-2). B: Reaction product with the cell lysate from 
E. coli BL21(DE3) transformed with pET-CSF26G1 (B-I) or pET3d 
(B-2). HPLC conditions were described previously [10]. 
coli BL21(DE3) bearing pET-CSF26G1 showed F26G activity 
under the IPTG induction, the activity was as weak as that of 
the cell lysate of E. coli transformed with pT7-CSF26G1 (Fig. 
4, Table 2), which was less than one hundredth of the activity 
found in the crude extract prepared from the plantlets (40 
nkat/mg protein) [11]. In addition, any band corresponding 
to CSF26GI was not detected by SDS-PAGE (data not 
shown). The reasons of these low expression levels of 
CSF26G1 cDNA in E. coli remain unknown. One possibility 
might be that the translated polypeptide cannot be folded 
properly since the coding sequence contains a transit peptide 
sequence which should be removed for the stable folding of a 
mature protein. The deduced amino acid sequence of 
CSF26G1 at residues 84-103 is highly similar to the N-term- 
inal sequence of the 54000 protein of the purified enzyme 
[4,11], following a sequence at residues 78-83 that shows the 
characteristic pattern of amino acids near signal-sequence 
cleavage sites [32]. Other expression systems such as that 
with the yeast system [33] should also be considered for 
further analysis of the recombinant protein. 
Gus-Maier et al. reported the purification of a protein 
K. Inoue et al./FEBS Letters 389 (1996) 273-277 277 
termed As-P60 from oat leaves and its cDNA cloning [22,34]. 
As-P60 was identified as avenacosidase, which is responsible 
for the catabolism of oat saponins, by immunological evi- 
dences [22,34]. The specificity of As-P60 was examined by 
using several glycosides of para-nitrophenyl derivatives 
[22,34]. However, the purified As-P60 was not shown to hy- 
drolyze avenacosides, nor was functional expression of the As- 
P60 cDNA reported. The native substrate of As-P60 in oat 
leaves remains unknown. 
In conclusion, the cDNA encoding a plant [3-glucosidase 
involved in saponin metabolism has been cloned for the first 
time in this study. Further studies using the CSF26G1 cDNA 
as a tool will elucidate the saponin metabolism at the molec- 
ular biological evel, and will address the question how F26G 
recognizes the skeleton of the furostanol glycosides. 
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